Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Tax Provisions (2019 - 2025)

Historic Tax Provisions for Inspire Medical Systems (INSP) over the last 7 years, with Q4 2025 value amounting to -$85.8 million.

  • Inspire Medical Systems' Tax Provisions fell 617443.34% to -$85.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$79.7 million, marking a year-over-year decrease of 168008.33%. This contributed to the annual value of -$79.7 million for FY2025, which is 171256.07% down from last year.
  • Inspire Medical Systems' Tax Provisions amounted to -$85.8 million in Q4 2025, which was down 617443.34% from $3.6 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Tax Provisions ranged from a high of $3.6 million in Q3 2025 and a low of -$85.8 million during Q4 2025
  • Its 5-year average for Tax Provisions is -$3.6 million, with a median of $231000.0 in 2022.
  • Per our database at Business Quant, Inspire Medical Systems' Tax Provisions soared by 810000.0% in 2022 and then plummeted by 617443.34% in 2025.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Tax Provisions stood at -$28000.0 in 2021, then skyrocketed by 503.57% to $113000.0 in 2022, then skyrocketed by 295.58% to $447000.0 in 2023, then soared by 215.88% to $1.4 million in 2024, then tumbled by 6174.43% to -$85.8 million in 2025.
  • Its last three reported values are -$85.8 million in Q4 2025, $3.6 million for Q3 2025, and $1.3 million during Q2 2025.